mhGAP Humanitarian Intervention Guide (mhGAP-HIG)
Clinical Management of Mental, Neurological and Substance Use Conditions in Humanitarian Emergencies
Overview
Adults and children affected by emergencies experience a substantial and diverse range of mental, substance use, and neurological problems.
The mhGAP Humanitarian Intervention Guide contains first-line management recommendations for mental, neurological and substance use conditions for non-specialist health-care providers in humanitarian emergencies where access to specialists and treatment options is limited. It is a simple, practical tool that aims to support general health facilities in areas affected by humanitarian emergencies in assessing and managing acute stress, grief, depression, post-traumatic stress disorder, psychosis, epilepsy, intellectual disability, harmful substance use and risk of suicide.
This new tool is an adaptation of WHO’s mhGAP Intervention Guide, a widely-used evidence-based manual for the management of these conditions in non-specialized health settings.
Addendum: Valproic acid (sodium valproate) in women and adolescent girls of reproductive age
Correction
Please note that two typos have been identified in the Epilepsy module of the mhGAP-Humanitarian Intervention Guide (mhGAP-HIG). This pertains to text in ‘Box EPI 2: Assessment and management of a person who is convulsing or is unconscious following a seizure’. The correct doses are as follows:
- Child glucose dose: 2–5 ml/kg of 10% glucose
- Adult glucose dose: 25-50 ml of 50% glucose
This correction has been made in the mhGAP-HIG manuals in all languages available on our website.
Related documents
Read more on mental health in emergencies